Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia

MAISTAS: a tool for automatic structural evaluation of alternative splicing products

(2011) M. Floris et al.   BIOINFORMATICS

Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors

(2011) W. MA et al.   International Journal of Laboratory Hematology

Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation

(2011) S. Apcher et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Pioneer Round of Translation: Features and Functions

(2010) Lynne E. Maquat et al.   CELL

ABL Alternative Splicing Is Quite Frequent in Normal Population - Letter

(2010) I. Santamaria et al.   MOLECULAR CANCER THERAPEUTICS

Variant Isoforms of BCR-ABL1 in Chronic Myelogenous Leukemia Reflect Alternative Splicing of ABL1 in Normal Tissue - Letter

(2010) J. S. Khorashad et al.   MOLECULAR CANCER THERAPEUTICS

Exon 7 Deletion in the bcr-abl Gene Is Frequent in Chronic Myeloid Leukemia Patients and Is Not Correlated with Resistance against Imatinib

(2010) J.-B. Gaillard et al.   MOLECULAR CANCER THERAPEUTICS

Verification of alternative splicing variants based on domain integrity, truncation length and intrinsic protein disorder

(2010) Hedi Hegyi et al.   NUCLEIC ACIDS RESEARCH

BCR-ABL Truncation due to Premature Translation Termination as a Mechanism of Resistance to Kinase Inhibitors

(2009) Wanlong Ma et al.   ACTA HAEMATOLOGICA

Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia

(2009) D. Milojkovic et al.   CLINICAL CANCER RESEARCH

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

(2009) Michele Baccarani et al.   JOURNAL OF CLINICAL ONCOLOGY

ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia

(2008) T. Ernst et al.   HAEMATOLOGICA

An Intron-Derived Insertion/Truncation Mutation in the BCR-ABL Kinase Domain in Chronic Myeloid Leukemia Patients Undergoing Kinase Inhibitor Therapy

(2008) Jennifer Laudadio et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia

(2008) D W Sherbenou et al.   LEUKEMIA

Supplemental results of the detection of splicing variant with c-ABL exon 7 deletion by direct sequencing

(2008) Eun Hae Cho et al.   LEUKEMIA RESEARCH

BCR-ABL alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations

(2008) T.-S. Lee et al.   MOLECULAR CANCER THERAPEUTICS

Alternative isoform regulation in human tissue transcriptomes

(2008) Eric T. Wang et al.   NATURE

Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing

(2008) Qun Pan et al.   NATURE GENETICS

A recurrent splicing variant without c-ABL Exon 7 in Imatinib-resistant patients

(2007) Raphael P.M. Curvo et al.   LEUKEMIA RESEARCH

A novel method reveals that solvent water favors polyproline II over β-strand conformation in peptides and unfolded proteins: conditional hydrophobic accessible surface area (CHASA)

(2004) Patrick J. Fleming et al.   PROTEIN SCIENCE